Skip Navigation

Scott Armstrong, MD, PhD, recognized by ISSCR for contributions to basic and translational research in hematological disorders

The International Society for Stem Cell Research (ISSCR) announced in a recent press release that Scott Armstrong, MD, PhD, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, is the recipient of its 2019 Tobias Award Lecture. Armstrong will be recognized and present the Tobias Lecture at the ISSCR annual meeting that begins on June 26 in Los Angeles, Calif.

The ISSCR Tobias Award Lecture, started in 2016, is supported by the Tobias Foundation, and recognizes original and promising basic hematology research and direct translational or clinical research related to cell therapy in hematological disorders.

Armstrong's work has focused on discovery of developmental pathways that drive childhood cancers and developing new treatment approaches. He directs a prolific research program to develop treatments that target epigenetic mechanisms using new small molecule approaches.

"Armstrong's dedicated work on finding ways to treat childhood cancers is remarkable," said ISSCR President Douglas Melton. "He has made seminal discoveries into the molecular nature of leukemia stem cells and demonstrated the key roles that development and gene expression play in disease progression. His work has led to new therapies now in clinical trials in both adults and children."

Armstrong will deliver the Tobias Lecture in Plenary VII, on Saturday, June 29 at 4:05 p.m. PST.

Posted on March 25, 2019

  • Scott A. Armstrong, MD, PhD
  • Cancer Genetics, Childhood

Media Contacts

For all inquiries, call 617-632-4090 and ask to speak to a member of the media team. Please direct emails to media@dfci.harvard.edu.

Scott Armstrong, MD, PhD, Dana-Farber/Boston Children's Cancer and Blood Disorders Center